BucindololCAS: 71119-11-4
MF: C22H25N3O2
MW: 363.45
A non-selective β-AR adrenoceptor antagonist.

Bucindolol (CAS 71119-11-4)

Bucindolol | CAS 71119-11-4 is rated 5.0 out of 5 by 1.
  • y_2020, m_1, d_25, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.4
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203860, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 138ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Synonym: 2-[2-hydroxy-3-[[1-(1H-indol-3-yl)-2-methylpropan-2-yl]amino]propoxy]benzonitrile
Application: A non-selective β-AR adrenoceptor antagonist
CAS Number: 71119-11-4
Purity: ≥98%
Molecular Weight: 363.45
Molecular Formula: C22H25N3O2
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Bucindolol is a non-selective β-AR adrenoceptor antagonist with additional α1A-AR adrenoceptor blocking activity. Ki values are 1.61, 1.20 and 68.9 nM for β1-AR (β1-), β2-AR(β2-) and α1A-AR (α1-adrenoceptors), respectively. Bucindolol also acts as a weak SR-2A and SR-2B (5-HT2A/2B) antagonist. Bucindolol displays vasodilatory and antihypertensive actions.

Appearance :
Powder
Physical State :
Solid
Solubility :
Soluble in DMSO (100 mM), and ethanol (50 mM).
Storage :
Store at 4° C
Melting Point :
229.56° C (Predicted)
Boiling Point :
~605.3° C at 760 mmHg (Predicted)
Density :
~1.2 g/cm3 (Predicted)
Refractive Index :
n20D 1.63 (Predicted)
IC50 :
CYP2D6: IC50 = 50 nM (human); OCT1: IC50 = 27.2 µM (human)
Ki Data :
β2-AR : Ki= 1.20 nM; β1-AR : Ki= 1.61 nM; α1A-AR : Ki= 68.9 nM
pK Values :
pKa: 13.76 (Predicted), pKb: 9.35 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
RTECS :
DI4637550
PubChem CID :
51045
MDL Number :
MFCD00865898
SMILES :
CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Bucindolol  Product Citations

See how others have used Bucindolol. Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 31360296  de Lima-Seolin, BG.|Nemec-Bakk, A.|Forsyth, H.|Kirk, S.|da Rosa Araujo, AS.|Schenkel, PC.|Belló-Klein, A.|Khaper, N.| et al. 2019. Oxid Med Cell Longev. 2019: 6325424.

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 113ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Maack et al Maack et al. (PubMed ID 12847069) found bucindolol was a partial agonist of human beta1-AR. -SCBT Publication Review
Date published: 2015-03-02
  • y_2020, m_1, d_25, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.4
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203860, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 10ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.